Treatment

JNJ-90189892 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
This study is testing a new drug, JNJ-90189892, sometimes with other medicines, for adults with acute myeloid leukemia (AML) or certain types of myelodysplastic neoplasms (MDS). It aims to find the safest and most effective doses for these blood cancers.
For: Leukemia, Myeloid, Acute · Myelodysplastic Neoplasms
Australia · France · Spain